Skip to content
ESPT
MARKETS / NYSE / Health care / Medical devices and instruments / CDRE
NYSE · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

Cadre Holdings, Inc. CDRE

6 fiscal years on record · USD · FY2025 reported · SEC filings only
$610.3M
▲ 7.5% YoY
$44.1M
▲ 22.2% YoY
$56.8M
▲ 117.7% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Cadre Holdings sells body armor, explosive ordnance disposal equipment, duty gear, remote handling solutions, containers for the storage of radioactive materials, and ventilation and containment solutions through direct and indirect channels. It has a total of 2,533 employees, of whom 1,805 are engaged in manufacturing, 236 in sales, marketing, product management and customer support, 211 in corporate functions, 219 in research and development and engineering, 27 as retail store associates and 35 in executive and administrative functions. No individual customer accounts for more than 10% of its total revenue. The company operates a global manufacturing footprint with sites across North America and Europe. Its history in the safety equipment business dates back to 1964. Alpha Safety, a subsidiary founded in 1986, provides technical products and services spanning the nuclear value chain.

Written from the business description in CADRE HOLDINGS, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 10 March 2026. Every sentence was checked against that document before publication.

Growth

USD 610.3M
Revenue, FY2025 · full 6-year series below
Revenue $M Net income $M
FY2025 · Revenue 610.3 · Net income 44.1
250.0M500.0M
202020232025
Compound annual growth
+10.1%
+8.6%
+96.5%
+2.8%
+85.4%
−6.1%
+5.9%
+10.3%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +8.6% a year over the five years to FY2025 — but profit grew slower: net income at +2.8%, earnings per share at −6.1%.

The share count rose from 0.03B to 0.04B over the period.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

7 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 11.0% · Net 7.2%
5%10%-5%
202020222025
ROE
FY2025 · ROE 14.0%
200%400%
202020222025
Three returns, three denominators.
Gross margin42.5%
Operating margin11.0%
Net margin7.2%
EBITDAUSD 86.0M

Each USD of equity produced 14 cents of profit this year.

Cash & shareholders

USD 15.4M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 56.8
25.0M50.0M
202020222025
Net buybacks $M Dividends $M
FY2025 · Dividends 15.4 · Net buybacks ·
10M20M
20212022202320242025
Dividends paidUSD 15.4M
Net buybacks·
Share of profit35.0%
Consecutive raises2 years

USD 15.4M in dividends — 35% of the year's profit went back to shareholders.

Total assetsUSD 770.0M
EquityUSD 317.8M
CashUSD 122.9M
Gross debtUSD 307.3M
Net debtUSD 184.4M
DepositsUSD 32.5M

Net debt stands at 58% of equity.

The 6-year record

6 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
CDRE, 6-year financial record
Metric 202520242023202220212020
Revenue $B0.60.60.50.50.40.4
Operating income $B0.10.10.10.00.10.0
EBITDA $B0.10.10.10.00.10.1
Income tax $B0.00.00.00.00.0−0.0
Net income $B0.00.00.00.00.00.0
Free cash flow $B0.10.00.10.00.00.0
EPS, diluted $1.020.901.020.160.441.40
Dividend / sh $0.100.090.080.08◌◌
Payout %353931198101—
ROE %14.014.221.34.626.0434.4
Shares out B0.040.040.040.040.030.03

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

MCK · COR · CAH · JNJ · HCA · LLY
Provenance

Company facts, as filed

How we verify · 0 failures in 30 reconciliationsAUDITED

Reconciled in 6 of the 6 fiscal years we could check. 26 checks were skipped: the balance sheet is not tagged before 2020. 13 checks were skipped: EPS is not tagged before 2020. 13 checks were skipped: revenue is not tagged before 2020.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityOrthopedic, Prosthetic & Surgical Appliances & Supplies
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2020

Share this section

Download image